Title
Category
Credits
Event date
Cost
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Attendance
$0.00
Program DescriptionThe understanding of MS pathophysiology has rapidly advanced in recent years, prompting reevaluation of concepts that were once considered understood.
  • 0.50 AAPA Category I CME
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Attendance
$0.00
Program DescriptionHistorically, patients with the most severe forms of spinal muscular atrophy (SMA) were largely unable to survive into adulthood, and those that did often were treated with a palliative approach. However, with the arrival of therapies that can dramatically shift the path of the disease, more and more patients are entering life-long adult care. Unfortunately, as this transition is a new consideration, many clinicians are still learning how to coordinate and manage it appropriately. 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
$0.00
Program DescriptionThe management of AD is at the beginning of a seismic paradigm shift. Historically, clinical strategy has been tailored to a therapeutic armamentarium that was nonspecific and directed solely at symptom management. This mindset coincides with a variety of outdated and potentially harmful assumptions such as the idea that early diagnosis provides limited clinical value. Now that anti-Aβ antibodies are making their way into the clinic, the entire spectrum of AD care, from diagnosis through therapy, must be re-engineered.